Association of rs10830963 MTNR1B and rs841853 SLC2A1 Polymorphism with Obesity on Type 2 Diabetes Patients: An Overview of Melatonin Receptor and Transporter

Yanuarita Tursinawati, Arum Kartikadewi, Ari Yuniastuti, R Susanti


BACKGROUND: One of the hormones that plays a role in glucose metabolism of Type 2 Diabetes Mellitus (T2DM) is melatonin. Its genetic variation is believed to play a significant role in the pathophysiology of obese and non-obese T2DM. The role of MTNR1B (melatonin receptor coding gene) and SLC2A1 (Glucose transporter 1/GLUT 1 transporter coding gene) on the risk of obese and non-obese T2DM patients is controversial. This study aims to analyze the association between the rs10830963 MTNR1B and rs841853 SLC2A1 polymorphism to the risk of Javanese obese T2DM.

METHODS: This was a cross-sectional study that involved 107 Javanese T2DM patients from primary heath care in Semarang. Furthermore, obese T2DM was defined by a body mass index (BMI) more than 25 kg/m2. The genetic variations examined were rs10830963 MTNR1B and rs841853 SLC2A1 polymorphism by PCR-RFLP methods. Blood biochemistry parameters were also examined. Allele and genotype frequencies of rs10830963 MTNR1B and rs841853 SLC2A1 polymorphisms were analyzed using the x2 test with p≤0.05 and 95% CI.

RESULTS: There was a significant association between rs10830963 MTNR1B polymorphisms in obese and nonobese T2DM (p=0.044) and the CG genotype increased the risk of obese T2DM. Furthermore, the allele and genotype frequency of rs841853 SLC2A1 polymorphism in both group had no significant difference, with a p=0.756 and p=0.802, respectively. There was also no significant difference in the biochemical parameters' in both groups of the two genetic variants studied.

CONCLUSION: The rs10830963 MTNR1B polymorphism is associated with the risk of obesity in Javanese T2DM patients but not for the rs841853 SLC2A1 polymorphism.

KEYWORDS: polymorphism, MTNR1B, SLC2A1, obese, diabetes mellitus

Full Text:



Kementrian Kesehatan RI. Profil Kesehatan Indonesia 2019. Jakarta: Kementrian Kesehatan RI; 2020, article.

Peschke E, Frese T, Chankiewitz E, Peschke D, Preiss U, Schneyer U, et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res. 2006; 40: 135-43, CrossRef.

Reiter RJ, Tan DX, Rosales-Corral S, Galano A, Jou MJ, Acuna-Castroviejo D. Melatonin mitigates mitochondrial meltdown: Interactions with SIRT3. Int J Mol Sci. 2018; 19: 2-28, CrossRef.

Hevia D, González-Menéndez P, Quiros-González I, Miar A, Rodríguez-García A, Tan DX, et al. Melatonin uptake through glucose transporters: A new target for melatonin inhibition of cancer. J Pineal Res. 2015; 58: 234-50, CrossRef.

Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, et al. Variants in the melatonin receptor 1B gene (MTNR1B) influence fasting glucose levels. Nat Genet. 2010; 41: 77-81, CrossRef.

Takeuchi F, Katsuya T, Chakrewarthy S, Yamamoto K, Fujioka A, Serizawa M, et al. Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. Diabetologia. 2010; 53: 299-308, CrossRef.

Kwak SH, Jang HC, Park KS. Finding genetic risk factors of gestational diabetes. Genomics Inf. 2012; 10: 239-43, CrossRef.

Sparsø T, Bonnefond A, Andersson E, Bouatia-Naji N, Holmkvist J, Wegner L, et al. G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: Studies involving 19,605 Europeans. Diabetes. 2009; 58: 1450-6, CrossRef.

Song JY, Wang HJ, Ma J, Xu ZY, Hinney A, Hebebrand J, et al. Association of the rs10830963 polymorphism in MTNR1B with fasting glucose levels in Chinese children and adolescents. Obes Facts. 2011; 4: 197-203, CrossRef.

Du B, Liu S, Cui C, Wang S, Cui W. Association between glucose transporter 1 rs841853 polymorphism and type 2 diabetes mellitus risk may be population specific. J Diabetes. 2013; 5: 291-9, CrossRef.

Ma RCW, Chan JCN. Type 2 diabetes in East Asians: Similarities and differences with populations in Europe and the United States. Ann NY Acad Sci. 2013; 1281: 64-91, CrossRef.

George AM, Jacob AG, Fogelfeld L. Lean diabetes mellitus: An emerging entity in the era of obesity. World J Diabetes. 2015; 6: 613-20, CrossRef.

Kong X, Xing X, Hong J, Zhang X, Yang W. Genetic variants associated with lean and obese type 2 diabetes in a Han Chinese population A case-control study. Medicine (Baltimore). 2016; 95: e3841, CrossRef.

Timpson NJ, Lindgren CM, Weedon MN, Randall J, Ouwehand WH, Strachan DP, et al. Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Diabetes. 2009; 58: 505-10, CrossRef.

Boutsouris K, Poumpouridou N, Katsarou M, S, Gourzi TF, Tentolouris K, et al. Frequency distribution of TCF7l2, MTNR1B, CDKAl1, SLC30A8 and FTO gene polymorphisms predisposing to type II diabetes mellitus and/or obesity in a greek population and their impact in personalized medicine. Arch Balk Med Union. 2016; 51: 157-63, article.

Cipolla-Neto J, Amaral FG, Afeche SC, Tan DX, Reiter RJ. Melatonin, energy metabolism, and obesity: A review. J Pineal Res. 2014; 56: 371-81, CrossRef.

Szewczyk-Golec K, Rajewski P, Gackowski M, Mila-Kierzenkowska C, Wesołowski R, Sutkowy P, et al. Melatonin supplementation lowers oxidative stress and regulates adipokines in obese patients on a calorie-restricted diet. Oxid Med Cell Longev. 2017; 2017: 8494107, CrossRef.

De Luis DA, Izaola O, Primo D, Aller R. Association of the rs10830963 polymorphism in MTNR1B with fasting glucose, serum adipokine levels and components of metabolic syndrome in adult obese subjects. Nutr Hosp. 2019; 36: 60-5, CrossRef.

Pontiroli AE, Capra F, Veglia F, Ferrari M, Xiang KS, Bell GI, et al. Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations. Acta Diabetol. 1996; 33: 193-7, CrossRef.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003; 42: 1206-52, CrossRef.

Budiyati R, Lukito W, Wijaya A. Correlation between visfatin, insulin resistance (homeostasis model assesment of insulin resistance), inflammation (high sensitivity C-reactive protein) and HDL cholesterol concentration in individuals with visceral obesity. Indones Biomed J. 2010; 2: 61-5, CrossRef.

Lubis SM, Fattah M, Damanik HA, Batubara JRL. Association of fat mass and obesity-associated Gene (FTO) rs9939609 variant with early onset obesity among bataknese and Chinese children in Indonesia: A case-control study. Indones Biomed J. 2017; 9: 147-52, CrossRef.

Cauchi S, Choquet H, Gutiérrez-Aguilar R, Capel F, Grau K, Proença C, et al. Effects of TCF7L2 polymorphisms on obesity in European populations. Obesity. 2008; 16: 476-82, CrossRef.

Voight BF, Scott LJ, Steinthorsdottir V, Andrew P, Aulchenko YS, Thorleifsson G, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010; 42: 579-89, CrossRef.

Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, Sjögren M, et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes. 2006; 55: 2890-5, CrossRef.

Tursinawati Y, Hakim RF, Rohmani A, Kartikadewi A, Sandra F. CAPN10 SNP-19 is associated with susceptibility of type 2 diabetes mellitus: A Javanese case-control study. Indones Biomed J. 2020; 12: 109-14, CrossRef.

Cauchi S, Nead KT, Choquet H, Horber F, Potoczna N, Balkau B, et al. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: Implications for association studies. BMC Med Genet. 2008; 9: 45, CrossRef.

Linder K, Wagner R, Hatziagelaki E, Ketterer C, Heni M, Machicao F, et al. Allele summation of diabetes risk genes predicts impaired glucose tolerance in female and obese individuals. PLoS One. 2012; 7: e38224, CrossRef.

Amini S, Javanmardi M, Mokarizadeh A, Maroofi F, Jalali C, Azadi NA, et al. Association of HaeIII single nucleotide polymorphisms in the SLC2A1 gene with risk of diabetic nephropathy; evidence from Kurdish patients with type 2 diabetes mellitus. Qjm. 2016; 109: 399-404, CrossRef.

Freemerman AJ, Johnson AR, Sacks GN, Milner JJ, Kirk EL, Troester MA, et al. Metabolic reprogramming of macrophages: Glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J Biol Chem. 2014; 289: 7884-96, CrossRef.

Triana R, Meiliana A, Halimah E, Wijaya A. Relationship between circulating protein p53 and high sensitivity C-reactive protein in central obesity men with inflammaging. Indones Biomed J. 2019; 11: 59-62, CrossRef.

Ling Y, Li X, Gu Q, Chen H, Lu D, Gao X. A common polymorphism rs3781637 in MTNR1B is associated with type 2 diabetes and lipids levels in Han Chinese individuals. Cardiovasc Diabetol. 2011; 10: 27, CrossRef.

Stefanidis I, Tziastoudi M, Tsironi EE, Dardiotis E, Tachmitzi SV, Fotiadou A, et al. The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis. Ren Fail. 2018; 40: 561-76, CrossRef.

Stefanidis I, Kytoudis K, Papathanasiou AA, Zaragotas D, Melistas L, Kitsios GD, et al. XbaI GLUT1 gene polymorphism and the risk of type 2 diabetes with nephropathy. Dis Markers. 2009; 27: 29-35, CrossRef.

Rizvi S. Association of genetic variants with diabetic nephropathy. World J Diabetes. 2014; 5: 809-16, CrossRef.


Indexed by:






The Prodia Education and Research Institute